---
title: Serum Metal Ion Concentrations Following Primary Hip Arthroplasty
nct_id: NCT00714610
overall_status: COMPLETED
sponsor: University of Utah
study_type: OBSERVATIONAL
primary_condition: Healthy
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00714610.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00714610"
ct_last_update_post_date: 2014-02-04
last_seen_at: "2026-05-12T06:08:01.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Serum Metal Ion Concentrations Following Primary Hip Arthroplasty

**Official Title:** Serum Metal Ion Concentrations Following Unilateral Versus Bilateral Large Head Metal on Metal Primary Hip Arthroplasty

**NCT ID:** [NCT00714610](https://clinicaltrials.gov/study/NCT00714610)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 39
- **Lead Sponsor:** University of Utah
- **Conditions:** Healthy
- **Start Date:** 2007-08
- **Completion Date:** 2013-06
- **CT.gov Last Update:** 2014-02-04

## Brief Summary

The objective of this study is to compare serum chromium and cobalt levels of patients who have undergone metal on metal total hip arthroplasty. It is unknown if the presence of bilateral well-functioning large-head metal-on-metal (MOM) total hip arthroplasties (THAs) leads to higher serum metal ion concentrations than unilateral MOM THA. Elevated levels (chromium, 17 μg/L; cobalt, 19 μg/L) have been associated with poorly functioning MOM THA with metallosis. Fourteen patients having undergone bilateral and 25 patients having undergone unilateral large-head primary MOM THA were compared. Harris Hip Scores, University of California Los Angeles activity scores, radiographs, serum creatinine, and serum cobalt and chromium levels were obtained.

## Detailed Description

The objective of this study is to compare serum chromium and cobalt levels of patients who have undergone metal on metal total hip arthroplasty.

The effect of the presence of bilateral large-head MOM THA on circulating metal ions levels has not been thoroughly studied. Metal ion levels in patients with unilateral MOM vs bilateral MOM resurfacing and small-head THA have been reported; however, to the investigators knowledge, no study has investigated the differences in serum metal ion levels in unilateral vs bilateral largehead (≥38 mm) MOM THA. The objective of this study was to compare serum cobalt and chromium levels in patients who have undergone unilateral vs bilateral large-head MOM THA to better understand the effect of the presence of bilateral implants on circulating metal ion levels. The investigators believe that further understanding baseline levels in well-functioning MOM THA will increase the clinical utility of checking serum metal ion levels in the workup of the painful MOM THA. The investigators hypothesis was that serum metal ion levels in patients with well-functioning bilateral large-head MOM THA would be higher than levels in patients with well functioning unilateral large-head MOM THA, but these levels would not approach those seen with metallosis.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* undergone unilateral large-head (≥38 mm) primary MOM THA
* undergone bilateral large-head primary MOM THA
* 18 years old or older
* at least one year out from their index procedure
* had well-positioned components

Exclusion Criteria:

* other metal implants
* renal insufficiency (estimated creatinine clearance b30 mL/min)
* component malpositioning (cup inclination angle N55°)
* evidence of osteolysis on radiographs
* a poorly functioning hip (Harris Hip Score \[HHS\] b70)
```

## Arms

- **1** — Unilateral or bilateral large head metal on metal primary total hip arthroplasty

## Primary Outcomes

- **Serum Metal Ion Concentrations** _(time frame: 1 year)_

## Locations (1)

- University of Utah Orthopaedic Center, Salt Lake City, Utah, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of utah orthopaedic center|salt lake city|utah|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00714610.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00714610*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*